CD79A and COVID-19: Unique virus-specific antibody characteristics distinguished survivors from non-survivors of COVID-19: non-survivors exhibited altered dynamic of S-specific IgM and IgA responses (A), with a delayed instauration of S and RBD-specific IgG response (B).